Authors: Meschler, JP Howlett, AC Madras, BK

Citation: Jp. Meschler et al., Cannabinoid receptor agonist and antagonist effects on motor function in normal and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)-treated non-human primates, PSYCHOPHAR, 156(1), 2001, pp. 79-85

Authors: Meschler, JP Howlett, AC

Citation: Jp. Meschler et Ac. Howlett, Signal transduction interactions between CB1 cannabinoid and dopamine receptors in the rat and monkey striatum, NEUROPHARM, 40(7), 2001, pp. 918-926

Authors: Meschler, JP Conley, TJ Howlett, AC

Citation: Jp. Meschler et al., Cannabinoid and dopamine interaction in rodent brain: effects on locomotoractivity, PHARM BIO B, 67(3), 2000, pp. 567-573

Authors: Meschler, JP Clarkson, FA Mathews, PJ Howlett, AC Madras, BK

Citation: Jp. Meschler et al., D-2, but not D-1 dopamine receptor agonists potentiate cannabinoid-inducedsedation in nonhuman primates, J PHARM EXP, 292(3), 2000, pp. 952-959

Authors: Meschler, JP Kraichely, DM Wilken, GH Howlett, AC

Citation: Jp. Meschler et al., Inverse agonist properties of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxypheny-1H-pyrazole-3-carboxylic acid phenylamide (CP-272871) for the CB1 cannabinoid receptor, BIOCH PHARM, 60(9), 2000, pp. 1315-1323

Authors: Meschler, JP Howlett, AC

Citation: Jp. Meschler et Ac. Howlett, Thujone exhibits low affinity for cannabinoid receptors but fails to evokecannabimimetic responses, PHARM BIO B, 62(3), 1999, pp. 473-480